Mirum Pharmaceuticals, Inc. MIRM Lessee Operating Lease Liability Undiscounted Excess Amount
Lessee Operating Lease Liability Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s lessee operating lease liability undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s lessee operating lease liability undiscounted excess amount?
- Mirum Pharmaceuticals, Inc. (MIRM) reported lessee operating lease liability undiscounted excess amount of $2.74M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s lessee operating lease liability undiscounted excess amount changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s lessee operating lease liability undiscounted excess amount increased by 84.5% year-over-year, from $1.48M to $2.74M.